Suchergebnisse - "Safra, Tamar"

PubPharm (105)

41

A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2-Mutated Ovarian Carcinoma or Other Solid Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2017

von Kristeleit, R. | Shapiro, G. | Burris, H. | +17

42

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

enthalten in: The New England journal of medicine | 2016

von Mirza, M. | Monk, B. | Herrstedt, J. | +118

CommentIn: Nat Rev Clin Oncol. 2017 Feb;14 (2):71. - PMID 27958296

43

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy : an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial

enthalten in: The Lancet. Oncology | 2016

von Ledermann, J. | Harter, P. | Gourley, C. | +15

CommentIn: Lancet Oncol. 2016 Nov;17 (11):1474-1475. - PMID 27819228

44

Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer

enthalten in: British journal of cancer | 2016

von Ledermann, J. | Harter, P. | Gourley, C. | +14

45

Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation : Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy

enthalten in: Cancer | 2016

von Matulonis, U. | Harter, P. | Gourley, C. | +13

46

Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel

enthalten in: Breast cancer research and treatment | 2016

von Yablonski-Peretz, T. | Paluch-Shimon, S. | Gutman, L. | +17

47

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial

enthalten in: The lancet / Oncology | 2016

von Ledermann, J. | Harter, P. | Gourley, C. | +15

48

Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer

enthalten in: The British journal of cancer | 2016

von Ledermann, J. | Harter, P. | Gourley, C. | +14

49

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial

enthalten in: The lancet / Oncology | 2016

von Ledermann, J. | Harter, P. | Gourley, C. | +15

50

Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel

enthalten in: Breast cancer research and treatment | 2015

von Yablonski-Peretz, T. | Paluch-Shimon, S. | Gutman, L. | +17